Biotech Archives - Page 732 of 795

1 minute read

Apellis Shares Show Mixed Reaction After Positive 2 Years Data From Late-Stage Retinal Disorder Study

August 24, 9:42 AM

Apellis Pharmaceuticals (NASDAQ: APLS) revealed top-line data readout at 24 months showing increased effects over time with intravitreal pegcetacoplan in the Phase 3 DERBY and OAKS studies in geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

APLS

1 minute read

Ainos Seeks FDA Nod For Mid-Stage Covid-19 Study

By Ragothaman Srinivasan

August 24, 7:50 AM

Ainos, Inc. (NASDAQ: AIMD) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for conducting a Phase 2 trial of its drug candidate VELDONA, for treatment of mild symptoms related to COVID-19.

AIMD

1 minute read

BioCardia Enters Agreement with BlueRock Therapeutics To Provide Enabling Catheter Biotherapeutic Delivery Product Candidates For BlueRock’s Cell Therapy To Treat Heart Failure

By Bill Haddad

August 24, 7:03 AM

BioCardia®, Inc. (NASDAQ:BCDA), today announced that it has entered into an agreement with BlueRock Therapeutics LP for the delivery of BlueRock's cell therapy product candidates for the treatment of

BCDA

3 minute read

Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 23, 6:53 PM

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck‘s (NYSE:MRK) lead asset MK-2060…

AMGN

1 minute read

Boxed Warnings May Not Hinder This Depression Drug’s Broad Market Penetration, Analyst Says

By Vandana Singh

August 23, 3:34 PM

Last week, Axsome Therapeutics Inc’s (NASDAQ:AXSM) major depression candidate received the much-awaited FDA approval. HC Wainwright notes that the approval comes roughly…

AXSM

1 minute read

Mizuho Is Bullish On This Schizophrenia-Focused Stock, Read Why

By Vandana Singh

August 23, 3:32 PM

Mizuho updated the price target for Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) from $27 to $32 keeping the Neutral rating. The updated model…

CERE

1 minute read

Moderna Plans US Application Submission For COVID-19 Omicron Adapted Booster ‘Very Soon’

By Vandana Singh

August 23, 3:28 PM

Moderna Inc (NASDAQ:MRNA) plans to file data with the FDA very soon, seeking approval for a booster shot targeting…

MRNA

1 minute read

FDA
News

‘Moderna Set to Seek FDA Approval of Booster Against Omicron Variants’ -Bloomberg

By Benzinga Newsdesk

August 23, 1:09 PM

https://www.bloomberg.com/news/articles/2022-08-23/moderna-says-us-filing-imminent-for-booster-against-new-variants?sref=y3YMCJ4e#xj4y7vzkg

MRNA

1 minute read

Sorrento Shares Pop After Interim Data From Lung Cancer Trial

By Vandana Singh

August 23, 11:58 AM

Sorrento Therapeutics Inc (NASDAQ: SRNE) announced positive results from a pivotal study of Abivertinib on 209 response evaluable, heavily pretreated NSCLC patients by an IRC assessment with matured long-term follow-up data.

AZN

1 minute read

FDA Approves Abbott’s New Spinal Cord Stimulation Device For Pain

By Vandana Singh

August 23, 11:28 AM

The FDA has approved Abbott Laboratories (NYSE:ABT) new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360 therapy. The next generation…

ABT